0000874015-20-000103.txt : 20200706
0000874015-20-000103.hdr.sgml : 20200706
20200706174702
ACCESSION NUMBER: 0000874015-20-000103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200701
FILED AS OF DATE: 20200706
DATE AS OF CHANGE: 20200706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PARSHALL B LYNNE
CENTRAL INDEX KEY: 0001073385
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 201014465
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330336973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
FORMER COMPANY:
FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-07-01
0000874015
IONIS PHARMACEUTICALS INC
IONS
0001073385
PARSHALL B LYNNE
C/O IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT
CARLSBAD
CA
92010
1
0
0
0
Common Stock
2020-07-01
2020-07-01
4
M
0
1778
0
A
66575
D
Common Stock
2020-07-02
2020-07-02
4
M
0
889
0
A
67464
D
Restricted Stock Units
2020-07-01
2020-07-01
4
M
0
1778
0
D
Common Stock
1778
5332
D
Restricted Stock Units
2020-07-02
2020-07-02
4
M
0
889
0
D
Common Stock
889
1777
D
Restricted Stock Units
0
2020-07-01
2020-07-01
4
A
0
5333
0
A
Common Stock
5333
5333
D
Director Stock Option (right to buy)
60.2
2020-07-01
2020-07-01
4
A
0
12000
0
A
2021-07-01
2030-06-30
Common Stock
12000
12000
D
Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards.
Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
Grant of July 1, 2020 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2020.
Grant of July 1, 2020 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2020.
/s/Patrick R. O'Neil, attorney-in-fact
2020-07-06